Teva Pharmaceutical Industries reported $1.98B in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Aspen Pharmacare ZAR 9.63B 3.1B Dec/2025
Cipla INR 29.71B 3.4B Jun/2026
Dr.Reddys Laboratories INR 39.22B 1.52B Jun/2026
Guangzhou Baiy CNY 16.27B 2.28B Jun/2026
Jiangsu Hengrui CNY 1.02B 68.56M Jun/2026
Kalbe Farma IDR 6.01T 554.92B Mar/2026
Richter Gedeon HUF 72.45B 1.13B Mar/2026
Sh Fosun Pharma CNY 5.22B 154.71M Jun/2026
Sun Pharmaceuticals INR 37.02B 9.01B Jun/2026
Teva Pharmaceutical Industries USD 1.98B 30M Jun/2026